Tackling the challenges posed by target flexibility in drug design

Author： Beier Christian   Zacharias Martin  

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.5, Iss.4, 2010-04, pp. : 347-359

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Flexibility as a Strategy in Nucleoside Antiviral Drug Design

By  

Current Medicinal Chemistry, Vol. 22, Iss. 34, 2015-11 ,pp. : 3910-12

Bentham Science Publishers

Access to resources Recommend Favorite

Accommodating Protein Flexibility for Structure-Based Drug Design

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 2, 2011-01 ,pp. : 171-178

Bentham Science Publishers

Access to resources Recommend Favorite

Challenges of Cancer Drug Design A Drug Metabolism Perspective

By  

Current Cancer Drug Targets, Vol. 1, Iss. 1, 2001-05 ,pp. : 1-32

Bentham Science Publishers

Access to resources Recommend Favorite

Intra- and Interdomain Flexibility in Matrix Metalloproteinases: Functional Aspects and Drug Design

By  

Current Pharmaceutical Design, Vol. 15, Iss. 31, 2009-11 ,pp. : 3592-3605

Bentham Science Publishers

Access to resources Recommend Favorite

Conformational Flexibility Models for the Receptor in Structure Based Drug Design

By  

Current Pharmaceutical Design, Vol. 9, Iss. 20, 2003-08 ,pp. : 1635-1648

Bentham Science Publishers

Access to resources Recommend Favorite